Statins, PPIs Lead Chronic Drug Classes In Part D “Induced Demand”
Executive Summary
Demand for statins and proton pump inhibitors showed solid gains among Medicare Part D enrollees in 2006, according to a recently released 1report from IMS Health
You may also be interested in...
Pharma Sales Growth: 2007 Starts High, But Expected To Taper By Year-End
BOSTON - Despite a strong start to 2007, growth in the pharmaceutical sector is expected to slow for the remainder of the year. According to IMS Health VP-Industry Relations Doug Long, "2007 has been a year that you could characterize as a fast start, slow finish.
Insurer Seeks To Recover ‘Illegal’ Daraprim Overcharges Due To Obstruction Of Generics
Proposed class action lawsuit by Blue Cross Blue Shield of Minnesota against Vyera Pharmaceuticals could set a precedent for other health insurer actions against manufacturers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: